The study investigated the association between long-term exposure to air pollution, how far people lived from green spaces and major roads, and the development of high blood pressure and some components of metabolic syndrome.
Dupixent (dupilumab) is given by injection every two weeks. It was approved to treat patients with nasal polyps and chronic rhinosinusitis -- defined as a prolonged inflammation of the sinuses and nasal cavity, the FDA said.
The study found that the risk of suffering a stroke was heightened in the weeks and months after any infection that required a trip to the hospital. But urinary tract infections (UTIs) showed the strongest link.
The commission says two boys were injured using the broken end of one of the recalled products. One of the boys lost a hand in the explosion.
